The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients

Chronic kidney disease (CKD) is currently defined as the presence of proteinuria and/or an eGFR

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BioMed research international 2020, Vol.2020 (2020), p.1-13
Hauptverfasser:	Michael, Ashour, Serraino, Giuseppe Filiberto, Licastro, Noemi, Ielapi, Nicola, Serra, Raffaele, Faga, Teresa, Gagliardi, Ida, Borrelli, Silvio, Battaglia, Yuri, Garofalo, Carlo, De Nicola, Luca, Andreucci, Michele, Provenzano, Michele, Mastroroberto, Pasquale
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological markers Biomarkers Biomarkers - metabolism Biomedical research Blood pressure Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - metabolism Cardiovascular Diseases - pathology Chronic kidney failure Clinical trials Complications and side effects Congestive heart failure Coronary artery disease Cystatin C Diabetes Diagnosis Epidermal growth factor receptors Fibrosis Health aspects Health risks Health services Heart diseases Heart failure Humans Kidney - metabolism Kidney - pathology Kidney diseases Kidneys Medical prognosis Mortality Patient outcomes Patients Predictions Prognosis Proteinuria Renal Insufficiency, Chronic - metabolism Renal Insufficiency, Chronic - pathology Review Risk Assessment Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Chronic kidney disease (CKD) is currently defined as the presence of proteinuria and/or an eGFR
ISSN:	2314-6133 2314-6141
DOI:	10.1155/2020/2314128